GeneDx
WGS · NASDAQ
Bulios Fair Price
$68.25
32.5% downside
Trenutna cena
$101.1
Po podatkih Bulios Fair Price je delnica WGS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
GeneDx is a biotechnology company specializing in genomic testing, particularly exome and genome sequencing, aimed at diagnosing rare and ultra-rare genetic disorders. Founded in 2000, the company is headquartered in Gaithersburg, Maryland. In 2021, GeneDx merged with Sema4 Holdings, strengthening its position in genomic testing. In 2024, the company achieved a significant financial turnaround, reporting its first adjusted net income in the third quarter and a year-over-year revenue increase of 52% to $76.6 million. GeneDx's shares are traded on NASDAQ under the symbol WGS.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Katherine A. Stueland
Employees
1,300
Headquarters
Stamford
Prihajajoči dogodki
Earnings
Upcoming earnings report